Adaptation of a Cost-Utility Model of Rasagiline in the Treatment of Parkinson's Disease in China
Abstract
Authors
S Chen H Chen B Zhang H Shang KH Tan F Ma J Dorey A Le Lay
S Chen H Chen B Zhang H Shang KH Tan F Ma J Dorey A Le Lay
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now